{"id":55372,"date":"2023-03-30T18:03:25","date_gmt":"2023-03-30T16:03:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/"},"modified":"2023-03-30T18:03:25","modified_gmt":"2023-03-30T16:03:25","slug":"avochato-announces-integration-with-chatgpt-4-by-openai","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/","title":{"rendered":"Avochato Announces Integration with ChatGPT-4 by OpenAI"},"content":{"rendered":"<div>\n<p>\n<b>SMS and WhatsApp Conversations Enhanced by AI-Powered Technology<\/b>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/5\/Chatgpt.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751775\/5\/avochato_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751775\/21\/avochato_logo.jpg\"><\/a><\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/avochato?src=hash\" target=\"_blank\" rel=\"noopener\">#avochato<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.avochato.com&amp;esheet=53370831&amp;newsitemid=20230330005315&amp;lan=en-US&amp;anchor=Avochato&amp;index=1&amp;md5=b3e2727bc27985a90e664544a8615e6e\" rel=\"nofollow noopener\" shape=\"rect\">Avochato<\/a>, a leading provider of advanced messaging software for businesses, has announced an integration with ChatGPT-4, the latest generation of OpenAI&#8217;s advanced natural language processing model. This collaboration aims to revolutionize the way businesses communicate with their customers, offering a faster and more efficient messaging experience.\n<\/p>\n<p>\nAvochato&#8217;s mobile messaging platform has already transformed the customer engagement landscape by allowing businesses to communicate with their customers via text messages, a method that has proven to be convenient and effective. With the integration of ChatGPT-4, users of the Avochato platform will have the ability to leverage this technology to respond to customer inquiries with increased accuracy and efficiency, providing a more seamless and intuitive communication experience.\n<\/p>\n<p>\n&#8220;Avochato&#8217;s integration with ChatGPT-4 marks a major milestone in the evolution of customer engagement,&#8221; said Alex De Simone, CEO and Co-Founder of Avochato. &#8220;This collaboration will enable businesses to communicate with their customers more effectively and efficiently, significantly improving the overall customer experience.&#8221;\n<\/p>\n<p>\nKey features of the integration include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<span class=\"bwuline\">Automated Responses:<\/span> The integration allows businesses to automate common customer inquiries during and beyond business hours, reducing the workload on customer support teams and enabling them to focus on high priority items.\n<\/li>\n<li>\n<span class=\"bwuline\">Scalability:<\/span> The combined power of Avochato and ChatGPT-4 enables businesses to scale their customer support efforts without the need for additional coverage, reducing operational costs and increasing efficiency.\n<\/li>\n<li>\n<span class=\"bwuline\">Personalization:<\/span> ChatGPT-4 allows for a more personalized and human-like interaction with customers than prior model versions.\n<\/li>\n<li>\n<span class=\"bwuline\">Improved Language Support:<\/span> ChatGPT-4&#8217;s extensive language capabilities allow Avochato customers to better cater to a global user base, offering support in multiple languages and breaking down communication barriers.\n<\/li>\n<\/ul>\n<p>\nAvochato\u2019s CTO and Co-Founder Christopher Neale shared, \u201cWe are excited about the potential of our collaboration with OpenAI&#8217;s ChatGPT-4. This cutting-edge technology will greatly enhance our platform&#8217;s capabilities, allowing our product roadmap to offer a long list of benefits to our team and our customers.\u201d\n<\/p>\n<p>\nFor more information about Avochato&#8217;s integration with ChatGPT, please contact <a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x73;&#x61;l&#x65;&#115;&#64;&#x61;&#118;&#x6f;&#99;h&#x61;&#116;o&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#115;&#x61;&#108;&#x65;&#115;&#x40;&#97;&#x76;o&#x63;h&#x61;t&#x6f;&#46;&#99;&#x6f;&#109;<\/a>.\n<\/p>\n<p>\nAbout Avochato\n<\/p>\n<p>\nNamed a 2022 Gartner Cool Vendor in AI and Automation, Avochato offers SOC2 and HIPAA compliant advanced messaging software for support, sales, and operations teams. The company is backed by leading institutional investors including Amity Ventures, Base Ventures, Burst Capital, Gaingels, and XSeed Capital. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.avochato.com&amp;esheet=53370831&amp;newsitemid=20230330005315&amp;lan=en-US&amp;anchor=www.avochato.com&amp;index=2&amp;md5=eb503f9183f607282a9fce9f00eea598\" rel=\"nofollow noopener\" shape=\"rect\">www.avochato.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nNiki Camoro, <a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;m&#101;&#x64;&#x69;a&#64;&#x61;&#x76;o&#99;&#x68;&#x61;t&#111;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x65;&#100;&#x69;&#97;&#x40;&#97;&#x76;&#111;&#x63;&#104;&#x61;&#116;&#x6f;&#46;&#x63;&#111;&#x6d;<\/a>, 415-549-1361\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SMS and WhatsApp Conversations Enhanced by AI-Powered Technology SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#avochato&#8212;Avochato, a leading provider of advanced messaging software for businesses, has announced an integration with ChatGPT-4, the latest generation of OpenAI&#8217;s advanced natural language processing model. This collaboration aims to revolutionize the way businesses communicate with their customers, offering a faster and more efficient messaging &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55372","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SMS and WhatsApp Conversations Enhanced by AI-Powered Technology SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#avochato&#8212;Avochato, a leading provider of advanced messaging software for businesses, has announced an integration with ChatGPT-4, the latest generation of OpenAI&#8217;s advanced natural language processing model. This collaboration aims to revolutionize the way businesses communicate with their customers, offering a faster and more efficient messaging ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-30T16:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Avochato Announces Integration with ChatGPT-4 by OpenAI\",\"datePublished\":\"2023-03-30T16:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005315\\\/en\\\/1751772\\\/21\\\/Chatgpt.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/\",\"name\":\"Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005315\\\/en\\\/1751772\\\/21\\\/Chatgpt.jpg\",\"datePublished\":\"2023-03-30T16:03:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005315\\\/en\\\/1751772\\\/21\\\/Chatgpt.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005315\\\/en\\\/1751772\\\/21\\\/Chatgpt.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avochato-announces-integration-with-chatgpt-4-by-openai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avochato Announces Integration with ChatGPT-4 by OpenAI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/","og_locale":"en_US","og_type":"article","og_title":"Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend","og_description":"SMS and WhatsApp Conversations Enhanced by AI-Powered Technology SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#avochato&#8212;Avochato, a leading provider of advanced messaging software for businesses, has announced an integration with ChatGPT-4, the latest generation of OpenAI&#8217;s advanced natural language processing model. This collaboration aims to revolutionize the way businesses communicate with their customers, offering a faster and more efficient messaging ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-30T16:03:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Avochato Announces Integration with ChatGPT-4 by OpenAI","datePublished":"2023-03-30T16:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/","url":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/","name":"Avochato Announces Integration with ChatGPT-4 by OpenAI - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg","datePublished":"2023-03-30T16:03:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230330005315\/en\/1751772\/21\/Chatgpt.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/avochato-announces-integration-with-chatgpt-4-by-openai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Avochato Announces Integration with ChatGPT-4 by OpenAI"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55372"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55372\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}